Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

BioPlus Specialty Pharmacy Acquires California-Based Santa Barbara Specialty Pharmacy


News provided by

BioPlus Infusion Pharmacy

May 05, 2022, 11:00 ET

Share this article

Share toX

Share this article

Share toX

BioPlus Specialty Pharmacy Acquires California-Based  Santa Barbara Specialty Pharmacy
BioPlus Specialty Pharmacy Acquires California-Based Santa Barbara Specialty Pharmacy

BioPlus Infusion Pharmacy, the first and only infusion pharmacy with individualized, high-touch Tailored 2 You™ services and support, announced today that it has acquired California-based Santa Barbara Specialty Pharmacy (SBSP).

ALTAMONTE SPRINGS, Fla., and CARPINTERIA, Calif., May 5, 2022 /PRNewswire-PRWeb/ --BioPlus Infusion Pharmacy, the first and only infusion pharmacy with individualized, high-touch Tailored 2 You™ services and support, announced today that it has acquired California-based Santa Barbara Specialty Pharmacy (SBSP). BioPlus Infusion will be able to service considerably more patients in California and across the U.S. through the acquisition, which was finalized in late April 2022

Founded by pharmacist Marcel Sassola, SBSP has provided patients throughout the U.S. with personalized care, access to specialty infusion medications, and comprehensive clinical and customer support for more than 15 years. Infusion pharmacists and nurses at SBSP have achieved Immunoglobulin National Society (IgNS) certification –– the only nationally-recognized certification for Ig pharmacists and nurses. This certification ensures that assessment, validation, and documentation of its Ig clinicians' knowledge, skills and overall clinical competence meet the most stringent patient care requirements.

In BioPlus Infusion, we found the perfect partner in order to enhance patient clinical outcomes, while striving to optimize each patient’s quality of life.

Post this

"Since BioPlus opened its doors over 30 years ago, our infusion patients and their providers could count on clinical excellence, improved medication access and the highest-quality patient experiences, tailored to them," stated Elvin Montanez, Pharm D, and Chief Operating Officer of BioPlus. "As a pharmacy leader who has built out multiple specialty pharmacies, Mr. Sassola shares BioPlus' long-term vision of meeting the high touch needs of patients with chronic conditions, such as blood disorders, with dignity and care. He and his team will continue to work with BioPlus to provide individualized infusion services and exceptional experiences within the reach of virtually every patient who needs us."

"Each patient has a unique infusion journey; no two are the same. Since its inception, Santa Barbara Specialty Pharmacy has recognized the need for providing patients with more than simply medication fills; it was built on personalized care and attention," according to Marcel Sassola, Founder and CEO of SBSP. "In BioPlus Infusion, we found the perfect partner in order to enhance patient clinical outcomes, while striving to optimize each patient's quality of life. I am excited for the opportunity to join forces with BioPlus and the team. I believe that together, BioPlus and SBSP can reach those patients while further developing payer, manufacturer, and clinical trial partner relationships."

SBSP is accredited by URAC in Specialty Pharmacy and has earned an 'Exemplary Status' accreditation in Home Infusion by the Compliance Team. As part of the BioPlus Infusion family, Santa Barbara Specialty Pharmacy will continue to operate under the same business name.

Discover more at http://www.BioPlusInfusion.com and http://www.SantaRx.com.

About BioPlus Infusion Pharmacy
Meet the first and only infusion pharmacy with individualized, high-touch Tailored 2 You™ services and support. While most infusion pharmacies practice a one-size-fits-all approach, BioPlus Infusion Pharmacy believes tailoring care to each patient is the best way to achieve optimal individualized outcomes.

From coast to coast, patients and their healthcare providers turn to BioPlus Infusion for IVIg, SCIg, infliximab and clotting factor therapies to treat rare and complex conditions such as oncology, primary immunodeficiency disease (PIDD), chronic inflammatory demyelinating polyneuropathy (CIPD), multi motor neuropathy (MMN), multiple sclerosis (MS), bleeding disorders and much more. The BioPlus Infusion service model is characterized by personalization, empathy, and close relationships with patient advocates and nurse concierges who have over 30 years of combined experience in supporting patients through their medication journeys.

BioPlus Infusion is backed by BioPlus Specialty Pharmacy. Ranked #1 by both patients and prescribers, BioPlus Specialty Pharmacy has been a trusted member of the specialty pharmacy industry for over 33 years and is part of the CarepathRx family of pharmacy and medication management solutions.

Experience the BioPlus Infusion Pharmacy difference. Visit http://www.BioPlusInfusion.com.

About Santa Barbara Specialty Pharmacy
Santa Barbara Pharmacy is a Specialty/Infusion home healthcare provider, composed of a team of professionals dedicated to providing comprehensive services in an ethical and a patient-focused environment. Our goal is to provide superior care to our clients and achieve the best outcomes, while maintaining a financially sound organization for the benefit of our employees, patients and our service partners.

Learn more at http://www.SantaRx.com.

Media Contact

Dr Roxie Mooney, DBA, BioPlus Infusion Pharmacy, 1 (407) 575-3220, [email protected]

Wendy Bacigalupi, MSC, Legacy DNA, (510) 703-6064, [email protected]

SOURCE BioPlus Infusion Pharmacy

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.